Lower rates of hypoglycaemia in older individuals with type 2 diabetes using insulin degludec versus insulin glargine U100: Results from SWITCH 2

AIM: This study aimed to investigate the safety of insulin degludec (degludec) in relation to age and risk of hypoglycaemia post hoc in individuals with type 2 diabetes (T2D) (SWITCH 2 trial). METHODS: In this crossover study, individuals with T2D who were at risk of hypoglycaemia were randomized to...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Diabetes Obes Metab
Huvudupphovsmän: Heller, Simon R., DeVries, J. Hans, Wysham, Carol, Hansen, Charlotte T., Hansen, Melissa V., Frier, Brian M.
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Ltd 2019
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6618254/
https://ncbi.nlm.nih.gov/pubmed/30891886
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13708
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk